Latest news
Mechanisms of Acquired Resistance to Trastuzumab and T-DXd in HER2-Positive Gastric Cancer: Insights from Spatial Profiling - Vera HealthVera Health · Sat, 08 Aug 2026 08:36:50 GMTVitamin B5 boosts anti-PD-1 therapy in HER2-positive gastric cancer, enhancing B–T interactions - Bioengineer.orgBioengineer.org · Wed, 05 Aug 2026 17:38:25 GMTFDA Approves Jideytro for Previously Treated ROS1-Positive Lung Cancer - news.cancerconnect.comnews.cancerconnect.com · Wed, 05 Aug 2026 03:51:34 GMTPromising New Option for Claudin 18.2‑Positive Gastric and GEJ Cancer - news.cancerconnect.comnews.cancerconnect.com · Mon, 03 Aug 2026 17:25:49 GMTVYLOY TM (zolbetuximab) in combination with chemotherapy is NOW AVAILABLE and approved for first-line treatm.. - ET PharmaET Pharma · Thu, 30 Jul 2026 08:50:50 GMTMohit Manrao: AstraZeneca Reports Positive Phase III Results in Gastric Cancer - OncodailyOncodaily · Thu, 30 Jul 2026 07:00:00 GMTSonesitatug Vedotin Extends Survival in Advanced Gastric Cancer - Cure TodayCure Today · Wed, 29 Jul 2026 19:41:06 GMTSonesitatug Vedotin Improves Survival in CLDN18.2-Positive Gastric Cancer - Targeted OncologyTargeted Oncology · Mon, 27 Jul 2026 16:08:21 GMT